Disruption of chromosome 11 in canine fibrosarcomas highlights an unusual variability of CDKN2B in dogs

BMC Veterinary Research

Volumn 5, Issue , 2009, Pages

  Aguirre Hernández, Jesús ^a   Milne, Bruce S ^a   Queen, Chris ^a   O'Brien, Patricia C M ^a   Hoather, Tess ^a   Haugland, Sean ^a   Ferguson Smith, Malcolm A ^a   Dobson, Jane M ^a   Sargan, David R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

CYCLIN DEPENDENT KINASE INHIBITOR 2B;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHEMISTRY; CHROMOSOME; DOG; DOG DISEASE; FEMALE; FIBROSARCOMA; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HETEROZYGOSITY LOSS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEIC ACID HYBRIDIZATION; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; CHROMOSOMES; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DOG DISEASES; DOGS; FEMALE; FIBROSARCOMA; GENETIC VARIATION; HUMANS; LOSS OF HETEROZYGOSITY; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; POLYMORPHISM, GENETIC; SEQUENCE ALIGNMENT;

EID: 73349139921     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-5-27     Document Type: Article

References (62)

1. Withrow SJ, Powers BE, Straw RC, Wilkins RM. Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop Relat Res 1991, 270:159-168.
2. Vail DM, MacEwen EG. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000, 18:781-792. 10.3109/07357900009012210, 11107448.
3. Hendrick MJ, Mahaffey EA, Moore FM, Vos JH, Walder EJ. Histological classification of mesenchymal tumors of skin and soft tissues of domestic animals 1998, Washington, D.C: American Registry of Pathology.
4. Sargan DR, Milne BS, Aguirre Hernandez J, O'Brien PC, Ferguson-Smith MA, Hoather T, Dobson JM. Chromosome rearrangements in canine fibrosarcomas. J Hered 2005, 96:766-773. 10.1093/jhered/esi122, 16251511.
5. Guyon R, Lorentzen TD, Hitte C, Kim L, Cadieu E, Parker HG, Quignon P, Lowe JK, Renier C, Gelfenbeyn B, Vignaux F, DeFrance HB, Gloux S, Mahairas GG, Andre C, Galibert F, Ostrander EA. A 1-Mb resolution radiation hybrid map of the canine genome. Proc Natl Acad Sci USA 2003, 100:5296-5301. 154339, 12700351, 10.1073/pnas.0831002100.
6. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006, 7:667-677. 10.1038/nrm1987, 16921403.
7. Ensembl. , http://www.ensembl.org
8. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, Kamal M, Clamp M, Chang JL, Kulbokas EJ, Zody MC, et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 2005, 438:803-819. 10.1038/nature04338, 16341006.
9. Bignell GR, Santarius T, Pole JC, Butler AP, Perry J, Pleasance E, Greenman C, Menzies A, Taylor S, Edkins S, Campbell P, Quail M, Plumb B, Matthews L, McLay K, Edwards PA, Rogers J, Wooster R, Futreal PA, Stratton MR. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res 2007, 17:1296-1303. 1950898, 17675364, 10.1101/gr.6522707.
10. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994, 368:753-756. 10.1038/368753a0, 8152487.
11. Sharpless NE. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 2005, 576:22-38.
12. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998, 1378:F115-177.
13. Reef S, Zalckvar E, Shifman O, Bialik S, Sabanay H, Oren M, Kimchi A. A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol Cell 2006, 22:463-475. 10.1016/j.molcel.2006.04.014, 16713577.
14. Reef S, Shifman O, Oren M, Kimchi A. The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein. Oncogene 2007, 26:6677-6683. 10.1038/sj.onc.1210485, 17486078.
15. Ueda Y, Koya T, Yoneda-Kato N, Kato JY. Small mitochondrial ARF (smARF) is located in both the nucleus and cytoplasm, induces cell death, and activates p53 in mouse fibroblasts. FEBS Lett 2008, 582:1459-1464. 10.1016/j.febslet.2008.03.032, 18381074.
16. Robertson KD, Jones PA. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Oncogene 1999, 18:3810-3820. 10.1038/sj.onc.1202737, 10445844.
17. Lin YC, Diccianni MB, Kim Y, Lin HH, Lee CH, Lin RJ, Joo SH, Li J, Chuang TJ, Yang AS, Kuo HH, Tsai MD, Yu AL. Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progression. Oncogene 2007, 26:7017-7027. 10.1038/sj.onc.1210507, 17486064.
18. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 2001, 413:83-86. 10.1038/35092584, 11544530.
19. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 2001, 413:86-91. 10.1038/35092592, 11544531.
20. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997, 91:649-659. 10.1016/S0092-8674(00)80452-3, 9393858.
21. Sharpless NE, Ramsey MR, Balasubramanian P, Castrillon DH, DePinho RA. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene 2004, 23:379-385. 10.1038/sj.onc.1207074, 14724566.
22. Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK, et al. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 1995, 10:1061-1067.
23. Lohmann DR. RB1 gene mutations in retinoblastoma. Hum Mutat 1999, 14:283-288. 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J, 10502774.
24. Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 1998, 12:845-859. 10.1038/sj.leu.2401043, 9639410.
25. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995, 1:686-692. 10.1038/nm0795-686, 7585152.
26. Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001, 264:42-55. 10.1006/excr.2000.5149, 11237522.
27. Orlow I, Drobnjak M, Zhang ZF, Lewis J, Woodruff JM, Brennan MF, Cordon-Cardo C. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. J Natl Cancer Inst 1999, 91:73-79. 10.1093/jnci/91.1.73, 9890173.
28. Koenig A, Bianco SR, Fosmire S, Wojcieszyn J, Modiano JF. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma. Vet Pathol 2002, 39:458-472. 10.1354/vp.39-4-458, 12126149.
29. Levine RA, Fleischli MA. Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines. Vet Pathol 2000, 37:54-61. 10.1354/vp.37-1-54, 10643981.
30. Fosmire SP, Thomas R, Jubala CM, Wojcieszyn JW, Valli VE, Getzy DM, Smith TL, Gardner LA, Ritt MG, Bell JS, Freeman KP, Greenfield BE, Lana SE, Kisseberth WC, Helfand SC, Cutter GR, Breen M, Modiano JF. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. Vet Pathol 2007, 44:467-478. 10.1354/vp.44-4-467, 17606508.
31. DeInnocentes P, Agarwal P, Bird RC. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer. J Cell Biochem 2009, 106:491-505. 10.1002/jcb.22034, 19130492.
32. Korgaonkar C, Zhao L, Modestou M, Quelle DE. ARF function does not require p53 stabilization or Mdm2 relocalization. Mol Cell Biol 2002, 22:196-206. 134207, 11739734, 10.1128/MCB.22.1.196-206.2002.
33. Llanos S, Clark PA, Rowe J, Peters G. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol 2001, 3:445-452. 10.1038/35074506, 11331871.
34. Kim SH, Mitchell M, Fujii H, Llanos S, Peters G. Absence of p16INK4a and truncation of ARF tumor suppressors in chickens. Proc Natl Acad Sci USA 2003, 100:211-216. 140929, 12506196, 10.1073/pnas.0135557100.
35. Chen YJ, Chang JG, Shih LS, Chen PH, Endo M, Whang-Peng J, Chen YM. Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. Int J Cancer 1997, 71:350-354. 10.1002/(SICI)1097-0215(19970502)71:3<350::AID-IJC7>3.0.CO;2-X, 9139866.
36. Cho JW, Jeong YW, Han SW, Park JB, Jang BC, Baek WK, Kwon TK, Park JW, Kim SP, Suh MH, Suh SI. Aberrant p16INK4A RNA transcripts expressed in hepatocellular carcinoma cell lines regulate pRb phosphorylation by binding with CDK4, resulting in delayed cell cycle progression. Liver Int 2003, 23:194-200. 10.1034/j.1600-0676.2003.00821.x, 12955883.
37. Baumgartner R, Fernandez-Catalan C, Winoto A, Huber R, Engh RA, Holak TA. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a. Structure 1998, 6:1279-1290. 10.1016/S0969-2126(98)00128-2, 9782052.
38. Li J, Byeon IJ, Ericson K, Poi MJ, O'Maille P, Selby T, Tsai MD. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A. Biochemistry 1999, 38:2930-2940. 10.1021/bi982286e, 10074345.
39. Li J, Mahajan A, Tsai MD. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 2006, 45:15168-15178. 10.1021/bi062188q, 17176038.
40. Lohi H, Young EJ, Fitzmaurice SN, Rusbridge C, Chan EM, Vervoort M, Turnbull J, Zhao XC, Ianzano L, Paterson AD, Sutter NB, Ostrander EA, Andre C, Shelton GD, Ackerley CA, Scherer SW, Minassian BA. Expanded repeat in canine epilepsy. Science 2005, 307:81. 10.1126/science.1102832, 15637270.
41. Fondon JW, Garner HR. Molecular origins of rapid and continuous morphological evolution. Proc Natl Acad Sci USA 2004, 101:18058-18063. 539791, 15596718, 10.1073/pnas.0408118101.
42. Gilley J, Fried M. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus. Oncogene 2001, 20:7447-7452. 10.1038/sj.onc.1204933, 11704876.
43. Krimpenfort P, Ijpenberg A, Song JY, Valk M, Nawijn M, Zevenhoven J, Berns A. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 2007, 448:943-946. 10.1038/nature06084, 17713536.
44. Byeon IJ, Li J, Ericson K, Selby TL, Tevelev A, Kim HJ, O'Maille P, Tsai MD. Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol Cell 1998, 1:421-431. 10.1016/S1097-2765(00)80042-8, 9660926.
45. Russo AA, Tong L, Lee JO, Jeffrey PD, Pavletich NP. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 1998, 395:237-243. 10.1038/26155, 9751050.
46. Li J, Poi MJ, Qin D, Selby TL, Byeon IJ, Tsai MD. Tumor suppressor INK4: quantitative structure-function analyses of p18INK4C as an inhibitor of cyclin-dependent kinase 4. Biochemistry 2000, 39:649-657. 10.1021/bi991281u, 10651629.
47. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994, 371:257-261. 10.1038/371257a0, 8078588.
48. Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, Koh J, Slingerland JM, Stampfer MR. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol Cell Biol 1997, 17:2458-2467. 232094, 9111314.
49. Reynisdottir I, Polyak K, Iavarone A, Massague J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 1995, 9:1831-1845. 10.1101/gad.9.15.1831, 7649471.
50. Li JM, Nichols MA, Chandrasekharan S, Xiong Y, Wang XF. Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J Biol Chem 1995, 270:26750-26753. 10.1074/jbc.270.45.26750, 7592908.
51. Milne BS, Hoather T, O'Brien PC, Yang F, Ferguson-Smith MA, Dobson J, Sargan D. Karyotype of canine soft tissue sarcomas: a multi-colour, multi-species approach to canine chromosome painting. Chromosome Res 2004, 12:825-835. 10.1007/s10577-005-5542-9, 15702421.
52. Li R, Mignot E, Faraco J, Kadotani H, Cantanese J, Zhao B, Lin X, Hinton L, Ostrander EA, Patterson DF, de Jong PJ. Construction and characterization of an eightfold redundant dog genomic bacterial artificial chromosome library. Genomics 1999, 58:9-17. 10.1006/geno.1999.5772, 10331940.
53. Yang F, O'Brien PC, Milne BS, Graphodatsky AS, Solanky N, Trifonov V, Rens W, Sargan D, Ferguson-Smith MA. A complete comparative chromosome map for the dog, red fox, and human and its integration with canine genetic maps. Genomics 1999, 62:189-202. 10.1006/geno.1999.5989, 10610712.
54. Benson G. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res 1999, 27:573-580. 148217, 9862982, 10.1093/nar/27.2.573.
55. Rozen S, Skaletsky J. Primer3 on the WWW for general users and for biologist programmers. Bioinformatics Methods and Protocols: Methods in Molecular Biology 2000, 365-386. Totowa, NJ: Humana Press, Krawetz S, Misener S.
56. Primer3 (v. 0.4.0). , http://frodo.wi.mit.edu/primer3/
57. HGVS, nomenclature for the description of sequence variations. , http://www.hgvs.org/mutnomen/
58. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000, 15:7-12. 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N, 10612815.
59. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948. 10.1093/bioinformatics/btm404, 17846036.
60. EMBL-EBI, ClustalW2. , http://www.ebi.ac.uk/Tools/clustalw2/
61. Clamp M, Cuff J, Searle SM, Barton GJ. The Jalview Java alignment editor. Bioinformatics 2004, 20:426-427. 10.1093/bioinformatics/btg430, 14960472.
62. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995, 59(Pt 1):97-105. 10.1111/j.1469-1809.1995.tb01608.x, 7762987.